company background image
300519 logo

Zhejiang Xinguang Pharmaceutical SZSE:300519 Stock Report

Last Price

CN¥11.25

Market Cap

CN¥1.8b

7D

-0.2%

1Y

-29.7%

Updated

14 Jun, 2024

Data

Company Financials

Zhejiang Xinguang Pharmaceutical Co., Ltd.

SZSE:300519 Stock Report

Market Cap: CN¥1.8b

300519 Stock Overview

Zhejiang Xinguang Pharmaceutical Co., Ltd.

300519 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends2/6

Zhejiang Xinguang Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Xinguang Pharmaceutical
Historical stock prices
Current Share PriceCN¥11.25
52 Week HighCN¥19.88
52 Week LowCN¥8.45
Beta0.20
1 Month Change-13.59%
3 Month Change-12.04%
1 Year Change-29.69%
3 Year Change-29.11%
5 Year Change-21.88%
Change since IPO28.06%

Recent News & Updates

Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40

May 26
Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40

Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)

Apr 16
Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)

Recent updates

Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40

May 26
Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40

Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)

Apr 16
Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)

Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement

Feb 26
Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement

Shareholder Returns

300519CN PharmaceuticalsCN Market
7D-0.2%-0.7%-0.07%
1Y-29.7%-11.9%-15.5%

Return vs Industry: 300519 underperformed the CN Pharmaceuticals industry which returned -11.9% over the past year.

Return vs Market: 300519 underperformed the CN Market which returned -15.5% over the past year.

Price Volatility

Is 300519's price volatile compared to industry and market?
300519 volatility
300519 Average Weekly Movement5.9%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 300519 has not had significant price volatility in the past 3 months.

Volatility Over Time: 300519's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998315Yue Jun Wangwww.xgpharma.com

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food. It offers pharmaceutical products for vascular and trauma diseases, including respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

Zhejiang Xinguang Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Xinguang Pharmaceutical's earnings and revenue compare to its market cap?
300519 fundamental statistics
Market capCN¥1.80b
Earnings (TTM)CN¥56.74m
Revenue (TTM)CN¥278.65m

31.7x

P/E Ratio

6.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300519 income statement (TTM)
RevenueCN¥278.65m
Cost of RevenueCN¥177.75m
Gross ProfitCN¥100.89m
Other ExpensesCN¥44.15m
EarningsCN¥56.74m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.35
Gross Margin36.21%
Net Profit Margin20.36%
Debt/Equity Ratio0%

How did 300519 perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

114%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.